EFFECT OF PAXHERBAL BITTERS ON INFLAMMATION AND ANTIOXIDANT STATUS IN MALE WISTAR RATS FED A HIGH FRUCTOSE DIET
Abstract
Modern diets are often high in fructose, and this has been associated with increased inflammation and oxidative stress. Herbal remedies like Paxherbal bitters have been suggested as possible remedies. This study aims at determining if the co-administration of Paxherbal bitters could prevent the inflammation and oxidative stress, which occurs when male Wistar rats are fed a high fructose diet. Twenty male Wistar rats, approximately 200g each, were divided into four groups: the control, high fructose diet with fructose water (HFD+FW), HFD+FW with Atorvastatin, and HFD+FW with Paxherbal bitters, groups. After a 28-day experimental period, blood samples were assessed for high-sensitive C-reactive protein (HsCRP), malondialdehyde (MDA), and total antioxidant capacity (TAC), using standard methods. Statistical analysis was done using the SPSS-20 package. Results has shown that rats on the high fructose diet, displayed significantly (P<0.05) elevated HsCRP (0.63±0.04 mg/dl) and MDA (0.32±0.01 µM) levels, compared to control levels (0.27±0.01 mg/dl; 0.10±0.01 µM). Both Atorvastatin and Paxherbal bitters significantly (P<0.05) prevented the elevation of HsCRP, while only Paxherbal bitters significantly (P<0.05) prevented the increase in MDA level (0.13±0.02 µM) compared to the level seen in the HFD+FW group. The high fructose diet significantly (P<0.05) reduced the TAC in the rats, but Atorvastatin and Paxherbal bitters preserved the TAC (0.38±0.03 µmol/ml; 0.49±0.04 µmol/ml) of their respective groups compared to that of the negative control group (0.21±0.06 µmol/ml). This study shows that Paxherbal bitters prevented the inflammation and oxidative stress induced by a high fructose intake, suggesting its co-administration, has some preventive therapeutic role.
References
Abdelrahman, AM, Al Suleimani, Y.M., Ashique, M., Manoj, P, and Ali, B.H. (2018). Effect of infliximab and tocilizumab on fructose-induced hyperinsulinaemia and hypertension in rats. Biomedicine & Pharmacotherapy, 105, 182–186. DOI: 10.1016/j.biopha.2018.05.118 DOI: https://doi.org/10.1016/j.biopha.2018.05.118
Anionye, J.C. and Onyeneke, E.C. (2016a). Study of the composition and invitro antioxidant capacity of Paxherbal bitters in relation to its uses. NISEB Journal, 63 (4): 51-62.
Anionye, J.C. and Onyeneke, EC (2016b). Study of the composition and invitro antioxidant capacity of Yoyo bitters. European Journal of Biological Sciences, 8 (3): 108-115. DOI:10.5829/idosi.ejbs.2016.108.115.
Anionye, J.C., Onyeneke, E.C. and Eze, G.I. (2015). Evaluation of the effect of Paxherbal bitters on albino rats. NISEB Journal, 15 (4): 142-154
Anionye, J.C., Onyeneke, E.C., Eze, G.I., Edosa, R.O., Agu, K.C., Omorowa, E.F. and Oghagbon, E.S. (2017). Evaluation of the effect of Yoyo bitters on albino rats. IDOSR Journal of Applied Sciences, 2(1): 1-24. www.idosr.org
Anionye, J.C., Onyeneke, E.C., Edosa, R.O., Egili, S, Ogunsanya, O.O, Onovughakpo-Sakpa, O.E., Anekwe, A.I. and Ofoha, P.C. (2018). Evaluation of the effect of a locally formulated high-salt and high-lipid diet on the liver function status, blood pressure and lipid profile of albino Wistar rats. International Journal of Biology, Pharmacy and Allied Sciences, 7(6): 1065- 1078. https://doi.org/10.31032/IJBPAS/2018/7.64467. DOI: https://doi.org/10.31032/IJBPAS/2018/7.6.4467
Anionye, J. C ., and Onyeneke E. C (2020). Pharmacological Evaluation of Paxherbal Bitters as a Supplement for the Prevention of High-Salt and High-Fat Diet-Induced Cardiovascular Diseases. IAA Journal of Biological Sciences, 6(1):44-60. www.iaajournals.org
Ballatori, N., Krance, S.M., Notenboom, S., Shi, S., Tieu, K., and Hammond, C.L. (2009). Glutathione dysregulation and the etiology and progression of human diseases. Biological Chemistry, 390(3), 191-214. doi: 10.1515/BC.2009.033 DOI: https://doi.org/10.1515/BC.2009.033
Basaranoglu, M., Basaranoglu, G., Sabuncu, T., & Sentürk, H. (2013) Fructose as a key player in the development of fatty liver disease. World Journal of Gastroenterology, 19(8), 1166-1172. DOI: 10.3748/wjg.v19.i8.1166 DOI: https://doi.org/10.3748/wjg.v19.i8.1166
Bray, G.A., Nielsen, S.J., & Popkin, B.M. (2004) Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. American Journal of Clinical Nutrition, 79(4), 537-543. DOI: 10.1093/ajcn/79.4.537 DOI: https://doi.org/10.1093/ajcn/79.4.537
Canadian Council on Animal Care (1984). Guide to the care and use of experimental animals. Ottawa: National Academy Press. Pp 150-152.
Elufioye, T.O. and Mada, O.O. (2018). GC-MS, FTIR, UV analysis and in vitro antioxidant activity of a Nigeria polyherbal mixture: Pax herbal bitters. Free Radicals and Antioxidants 8(2):74-81. DOI: 10.5530/fra.2018.2.12 DOI: https://doi.org/10.5530/fra.2018.2.12
EMDEX. (2007). Angiotensin Converting Enzyme (ACE) Inhibitors. In C. O. Obi (Ed.), The Complete Drug Formulary (based on WHO Model Formulary) for Nigeria’s Health Professionals (2007 Ed.). Lindoz Books International, Mississauga, Canada, pp. 168–172
Farah, V., Elased, K.M., Chen, Y., Key, M.P., Cunha, T.S., Irigoyen, M.C., & Morris, M. (2006) Nocturnal hypertension in mice consuming a high fructose diet. Autonomic Neuroscience, 130(1-2), 41-50. DOI: 10.1016/j.autneu.2006.05.006 DOI: https://doi.org/10.1016/j.autneu.2006.05.006
Fielding, D. and G. Metheron, (eds) (1991). Rabbits. The Tropical Agriculturalist (1st edn). CTA. Macmillan Education Ltd. Macmillan Publishers London, UK. Pp: 16–17.
Gersch, M. S., Mu, W., Cirillo, P., Reungjui, S., Zhang, L., Roncal, C., Sautin, Y. Y., Johnson, R. J., & Nakagawa, T. (2007). Fructose, but not dextrose, accelerates the progression of chronic kidney disease. American Journal of Physiology-Renal Physiology, 293, F1256-F1261. DOI: https://doi.org/10.1152/ajprenal.00181.2007
Ho, E., Karimi Galougahi, K., Liu, C. C., Bhindi, R., & Figtree, G. A. (2013). Biological markers of oxidative stress: Applications to cardiovascular research and practice. Redox biology, 1(1), 483–491. DOI: 10.1016/j.redox.2013.07.006 DOI: https://doi.org/10.1016/j.redox.2013.07.006
Jarukamjorn, K., Jearapong, N., Pimson, C., & Chatuphonprasert, W. (2016). A High-Fat, High-Fructose Diet Induces Antioxidant Imbalance and Increases the Risk and Progression of Nonalcoholic Fatty Liver Disease in Mice. Scientifica, 2016, 5029414. DOI: https://doi.org/10.1155/2016/5029414
Jegatheesan, P. & De Bandt, J.P. (2017) Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism. Nutrients, 9(3), 230. DOI: 10.3390/nu9030230 DOI: https://doi.org/10.3390/nu9030230
Johnson, R.J., Segal, M.S. and Sautin, Y.(2007). Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. The American Journal of Clinical Nutrition, 86(4), 899-906. DOI: 10.1093/ajcn/86.4.899 DOI: https://doi.org/10.1093/ajcn/86.4.899
Lin, W. C., and Lin, J. Y. (2011). Five bitter compounds display different anti-inflammatory effects through modulating cytokine secretion using mouse primary splenocytes in vitro. Journal of agricultural and food chemistry, 59(1), 184–192. DOI: 10.1021/jf103581r DOI: https://doi.org/10.1021/jf103581r
Lírio, L.M., Forechi L., Zanardo T.C., Batista H.M., Meira E.F., Nogueira, B.V., Mill, J.G. and Baldo, M.P. (2016). Chronic fructose intake accelerates non-alcoholic fatty liver disease in the presence of essential hypertension. Journal of Diabetes and its Complications, 30(1), 85-92. DOI: 10.1016/j.jdiacomp.2015.10.008 DOI: https://doi.org/10.1016/j.jdiacomp.2015.10.008
Malik, V.S., Popkin, B.M., Bray, G.A., Després, J.P., Willett, W.C., & Hu, F.B. (2010) Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care, 33(11), 2477-2483. DOI: 10.2337/dc10-1079 DOI: https://doi.org/10.2337/dc10-1079
Mendie, U.E. (2009). Yoyo bitters clinical report. Faculty of Pharmacy, Department of Pharmaceutics and Pharmaceutical Technology, University of Lagos, Lagos, Nigeria. Pp: 1-5.
Muriel, P., López-Sánchez, P., & Ramos-Tovar, E. (2021). Fructose and the Liver. International journal of molecular sciences, 22(13), 6969. DOI: 10.3390/ijms22136969 DOI: https://doi.org/10.3390/ijms22136969
MyBioSource (2019a). Rat high sensitivity C-reactive protein (Hs-CRP) ELISA kit user manual. San Diego, California, USA: MyBioSource Incorporated. Pp 1-5.
MyBioSource (2019b). Rat total antioxidant capacity (TAC) microplate assay kit user
manual. San Diego, California, USA: MyBioSource Incorporated. Pp 1-8.
Reaven, G. and Banting, M. (1988). Role of insulin resistance in human disease. Diabetes, 37(12):1595-607. DOI: 10.2337/diab.37.12.1595 DOI: https://doi.org/10.2337/diab.37.12.1595
Rippe, J. M., and Angelopoulos, T. J. (2013). Sucrose, high-fructose corn syrup, and fructose, their metabolism and potential health effects: what do we really know?. Advances in nutrition (Bethesda, Md.), 4(2), 236–245. DOI: 10.3945/an.112.002824 DOI: https://doi.org/10.3945/an.112.002824
Sathyapalan, T., Shepherd, J., Atkin, S. L., & Kilpatrick, E. S. (2013). The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes: a crossover study. Diabetes, obesity & metabolism, 15(8), 767–769. DOI: 10.1111/dom.12074 DOI: https://doi.org/10.1111/dom.12074
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., McGahan, J. P., Seibert, A., Krauss, R. M., Chiu, S., Schaefer, E. J., Ai, M., Otokozawa, S., Nakajima, K., Nakano, T., Beysen, C., Havel, P. J. (2009). Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. The Journal of clinical investigation, 119(5), 1322–1334. https://doi.org/10.1172/JCI37385. DOI: https://doi.org/10.1172/JCI37385
Tandiari, D., Yustisia, I., Santoso, A., Cangara, H., Hamid, F., & Daud, N. A. S. (2021). Effect of high-fat high fructose diet and carbon tetrachloride on high sensitivity C reactive protein (hsCRP) levels male Wistar rat. International Journal of Biomedical Science, 15(1). Retrieved June 1, 2021, from https://doi.org/10.15562/ijbs.v15i1.303 DOI: https://doi.org/10.15562/ijbs.v15i1.303
Tukur, K., Musawa, B. B., Abubakar, M. L., Muhammad, M. S., & AbbaH. S. (2024). Ethnobotanical survey of medicinal plants used traditionally for the management of various ailments in Kaura Namoda, Zamfara State, Nigeria. FUDMA Journal of Sciences, 8(2), 188 - 195. https://doi.org/10.33003/fjs-2024-0802-2277. DOI: https://doi.org/10.33003/fjs-2024-0802-2277
Varshney, R. and Kale, R.K. (1990). Effect of Calmodulin antagonist on radiation induced lipid peroxidation in microsomes. International Journal Radiation Biology, 58:733-743. DOI: 10.1080/09553009014552121 DOI: https://doi.org/10.1080/09553009014552121
Vijayalakshmi, T., Muthulakshmi, V. and Sachdanandam, P. (2000). Toxic studies on biochemical parameters carried out in rats with Serankottai nei, a siddha drug–milk extract of Semecarpus anacardium nut. Journal of Ethnopharmacology 69 (1): 9–15. DOI: 10.1016/s0378-8741(99)00020-3. DOI: https://doi.org/10.1016/S0378-8741(99)00020-3
Vivekananthan, D.P., Penn, M.S., Sapp, S.K., Hsu, A., Topol, E.J. (2003). Use of antioxidant vitamins for the prevention of cardiovascular disease: Meta-analysis of randomized trials. Lancet 361: 2017–2023. DOI: 10.1016/S0140-6736(03)13637-9 DOI: https://doi.org/10.1016/S0140-6736(03)13637-9
Copyright (c) 2024 FUDMA JOURNAL OF SCIENCES
This work is licensed under a Creative Commons Attribution 4.0 International License.
FUDMA Journal of Sciences
